Since CYP3A5 is the major P450 CYP isoform expressed in the prostate tissue, the effects observed in our experiments is primarily due to inhibition of CYP3A5 in the tested prostate cancer cell lines [13, 35]. This evidence concerns the gene CYP2B6 and prostate cancer.